Hyperkalemia associated with intravenous labetalol therapy for acute hypertension in renal transplant recipients

Clin Nephrol. 1990 Jun;33(6):269-71.


Three renal transplant recipients developed potentially life-threatening hyperkalemia after receiving intravenous labetalol for postoperative hypertension. Even as beta-adrenergic agonists find increasing use in the therapy of acute hyperkalemia, physicians should be aware of the potential of beta blockers to cause profound elevations of serum potassium.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Humans
  • Hyperkalemia / chemically induced*
  • Hypertension / drug therapy*
  • Infusions, Intravenous
  • Kidney Failure, Chronic / surgery
  • Kidney Transplantation*
  • Labetalol / adverse effects*
  • Labetalol / therapeutic use
  • Male
  • Middle Aged
  • Postoperative Complications / drug therapy*


  • Labetalol